PortalPublikationenImpact of high-risk disease on the efficacy of chimeric anti...

Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

Standard

Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients. / Gagelmann, Nico; Ayuk, Francis A; Klyuchnikov, Evgeny; Wolschke, Christine; Berger, Susanna Carolina; Kröger, Nicolaus.

in: HAEMATOLOGICA, Jahrgang 108, Nr. 10, 01.10.2023, S. 2799-2802.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Letter › Forschung › Begutachtung

Harvard

Gagelmann, N, Ayuk, FA, Klyuchnikov, E, Wolschke, C, Berger, SC & Kröger, N 2023, 'Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients', HAEMATOLOGICA, Jg. 108, Nr. 10, S. 2799-2802. https://doi.org/10.3324/haematol.2022.282510

APA

Gagelmann, N., Ayuk, F. A., Klyuchnikov, E., Wolschke, C., Berger, S. C., & Kröger, N. (2023). Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients. HAEMATOLOGICA, 108(10), 2799-2802. https://doi.org/10.3324/haematol.2022.282510

Vancouver

Gagelmann N, Ayuk FA, Klyuchnikov E, Wolschke C, Berger SC, Kröger N. Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients. HAEMATOLOGICA. 2023 Okt 1;108(10):2799-2802. https://doi.org/10.3324/haematol.2022.282510

Bibtex

@article{647d81f54e5a47989ec01691408393b2,
title = "Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients",
keywords = "Humans, Receptors, Chimeric Antigen/genetics, Multiple Myeloma/therapy, Immunotherapy, Adoptive/adverse effects, T-Lymphocytes, Cell- and Tissue-Based Therapy, B-Cell Maturation Antigen, Receptors, Antigen, T-Cell/genetics",
author = "Nico Gagelmann and Ayuk, {Francis A} and Evgeny Klyuchnikov and Christine Wolschke and Berger, {Susanna Carolina} and Nicolaus Kr{\"o}ger",
year = "2023",
month = oct,
day = "1",
doi = "10.3324/haematol.2022.282510",
language = "English",
volume = "108",
pages = "2799--2802",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "10",

}

RIS

TY - JOUR

T1 - Impact of high-risk disease on the efficacy of chimeric antigen receptor T-cell therapy for multiple myeloma: a meta-analysis of 723 patients

AU - Gagelmann, Nico

AU - Ayuk, Francis A

AU - Klyuchnikov, Evgeny

AU - Wolschke, Christine

AU - Berger, Susanna Carolina

AU - Kröger, Nicolaus

PY - 2023/10/1

Y1 - 2023/10/1

KW - Humans

KW - Receptors, Chimeric Antigen/genetics

KW - Multiple Myeloma/therapy

KW - Immunotherapy, Adoptive/adverse effects

KW - T-Lymphocytes

KW - Cell- and Tissue-Based Therapy

KW - B-Cell Maturation Antigen

KW - Receptors, Antigen, T-Cell/genetics

U2 - 10.3324/haematol.2022.282510

DO - 10.3324/haematol.2022.282510

M3 - Letter

C2 - 36815380

VL - 108

SP - 2799

EP - 2802

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 10

ER -